Humoral aspects of polymyositis/dermatomyositis

References

• Bohan A, Peter JB, Bowman BS, Pearson CM. A computer as-sisted analysis of 153 patients with polymyositis and dermatomyo-sitis. Medicine (Baltimore) 1977;56:255–86.
   PubMed Web of Science ®Google Scholar
• Reichlin M, Arnett FC. Multiplicity of antibodies in myositis sera. Arthritis Rheum 1984;27:1150–6.
   PubMed Web of Science ®Google Scholar
• Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas MC, Plotz PH, et al. A new approach to the classification of idiopathic inflamma-tory myopathy: myositis-specific autoantibodies define useful ho-mogeneous patient groups. Medicine (Baltimore) 1991;70:360–74.
   PubMed Web of Science ®Google Scholar
• Targoff IN. Autoantibodies in polymyositis. Rheum Dis Clin North Am 1992;18:455–82.
   PubMed Web of Science ®Google Scholar
• Targoff IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994;20:857–80.
   PubMed Web of Science ®Google Scholar
• Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleopro-teins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992;35:449–56.
   PubMed Web of Science ®Google Scholar
• Dang CV, Dang CV. Higher eukaryotic aminoacyl-tFtNA syn-thetases in physiologic and pathologic states. Mol Cell Biochem 1986;71:107–20.
   PubMed Web of Science ®Google Scholar
• Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum 1980;23:881–8.
   PubMed Web of Science ®Google Scholar
• Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tFtNA synthetase: a model for autoimmunity. Nature 1983;304:177–9.
   PubMed Web of Science ®Google Scholar
• Mathews MB, Reichlin M, Hughes GRV, Bernstein RM. Anti-threonyl-tFtNA synthetase, a second myositis-related autoanti-body. J Exp Med 1984;160:420–34.
   PubMed Web of Science ®Google Scholar
• Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tFtNA synthetase and tRNAida coexist and are associated with myositis. J Exp Med 1096163:1281–91.
   Google Scholar
• Targoff IN. Autoantibodies to aminoacyl-transfer RNA syn-thetases for isoleucine and glycine: two additional synthetases are antigenic in myositis. J Immunol 1990;144:1737–43.
   PubMed Web of Science ®Google Scholar
• Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999;162:2315–20.
   PubMed Web of Science ®Google Scholar
• Eriani G, Delarue M, Poch O, Gangloff J, Moras D. Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature 1990;347:203–6.
   Google Scholar
• Cusack S, Hartlein M, Leberman R. Sequence, structural and evolutionary relationships between class 2 aminoacyl-tFtNA synthetases. Nucleic Acids Res 1991;19: 3489–98.
   Google Scholar
• Targoff IN, Trieu EP, Miller FW. Reaction of anti-0J autoantibod-ies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tFtNA synthetase. J Clin Invest 1993;91: 2556–64.
   Google Scholar
• Plotz PH. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 1983;ii:824–6.
   Google Scholar
• Rosa MD, Hendrick JP, Lerner MR, Steitz JA. A mammalian tRNAHIS containing antigen is recognized by the polymyositis-specific antibody anti-Jo-1. Nucleic Acids Res 1983;11:853–69.
   PubMed Web of Science ®Google Scholar
• Targoff IN, Reichlin M. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol 1987;138:2874–82.
   PubMed Web of Science ®Google Scholar
• Gelpi C, Kanterewicz E, Gratacos J, Targoff IN, Rodriguez-Sanchez JL. Coexistence of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum 1996;39:692–7.
   Google Scholar
• Marguerie C, Bunn CC, Beynon HLC, Bernstein RM, Hughes JMB, So AK, et al. Polymyositis, pulmonary fibrosis and autoanti-bodies to aminoacyl-tFtNA synthetase enzymes. Q J Med 1990;77:1019–38.
   PubMedGoogle Scholar
• Targoff IN, Arnett FC, Reichlin M. Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum 1988;31:515–24.
   PubMed Web of Science ®Google Scholar
• Targoff IN, Arnett FC. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tFtNA synthetase). Am J Med 1990;88:241–51.
   PubMed Web of Science ®Google Scholar
• Targoff IN, Trieu EP, Plotz H, Miller FW. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992;35:821–30.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983;26:604–11.
   Google Scholar
• Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB, Turner-Warwick M, et al. Anti-Jo-1 antibody: a marker for myosi-tis with interstitial lung disease. Br Med J 1984;289: 151–2.
   Google Scholar
• Oddis CV, Medsger TA Jr, Cooperstein LA. A subluxing arthr-opathy associated with the anti-Jo-1 antibody in polymyositis/ dermatomyositis. Arthritis Rheum 1990;33:1640–5.
   PubMed Web of Science ®Google Scholar
• Hirakata M, Nakamura K, Kaburaki J, Suwa A, Mimori T, Kanazawa M, et al. Interstitial lung disease in patients with connec-tive tissue diseases (in Japanese). Jpn J Thorac Dis 1995;33:268–76.
   Google Scholar
• Hirakata M, Suwa A, Satoh S, Mimori T, Nagai S, Kitaichi M, et al. Circulating KL-6 (MUC1 mucin) in patients with interstitial lung disease and anti-asparaginyl-tFtNA synthetase autoantibodies. Arthritis Rheum 1999;42(Suppl.):S111.
   Google Scholar
• Hirakata M, Nagai S, Suwa A, Satoh S, Hama N, Ohsone Y, et al. Histological features of interstitial lung disease in patients with anti-glycyl tFtNA synthetase autoantibodies. Arthritis Rheum 1998;41(Suppl.):5323.
   Google Scholar
• Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tFtNA synthetase in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996;26:459–67.
   Google Scholar
• Hirakata M, Nakamura K, Okano Y, Suwa A, Inada S, Akizuki M, et al. Anti-alanyl tFtNA synthetase (PL-12) antibodies are asso-ciated with interstitial lung disease in Japanese patients. Arthritis Rheum 1995;38(Suppl.):S146.
   Google Scholar
• Walter P, Lingappa VR. Mechanism of protein translocation across the endoplasmic reticulum membrane. Annu Rev Cell Biol 1986;2:499–516.
   PubMedGoogle Scholar
• Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal recognition particle. Proc Natl Acad Sci USA 1986;83:9507–11.
   PubMed Web of Science ®Google Scholar
• Okada N, Mimori T, Mukai R, Kashiwagi H, Hardin JA. Charac-terization of human autoantibodies that selectively precipitate the 75L RNA component of the signal recognition particle. J Immunol 1987;138: 3129–223.
   Google Scholar
• Targoff IN, Johnson AE, Miller FW. Antibody to signal recogni-tion particle in polymyositis. Arthritis Rheum 1990;33:1361–70.
   PubMed Web of Science ®Google Scholar
• Hirakata M, Matsuura Y, Suwa A, Satoh S, Hama N, Ohsone Y, et al. Immunological and histopathological features of patients with anti-SRP autoantibodies. Arthritis Rheum 1997;40(Suppl.):5146.
   Google Scholar
• Bernstein RM, Bunn CC, Hughes GRV, Francoeur AM, Mathews MB. Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med 1984;2:105–20.
   Google Scholar
• Targoff IN, Hanas J. The polymyositis-associated Fer antigen is elongation factor la. Arthritis Rheum 1989;32(Suppl.):581.
   Google Scholar
• Targoff IN, Arnett FC, Berman L, O'Brien C, Reichlin M. Anti-KJ: a new antibody associated with myositis/lung syndrome that reacts with a translation-related protein. J Chin Invest 1989;84:162–72.
   Google Scholar
• Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985;28:796–803.
   PubMed Web of Science ®Google Scholar
• Targoff IN, Nilasena DS, Trieu EP, Arnett FC, Pachman LM, Callen JP, et al. Clinical features and immunologic testing of pa-tients witn anti-Mi-2 antibodies. Arthritis Rheum 1990;33(Suppl.): S72.
   Google Scholar
• Seeling HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E. The major dermatomyositis-specific Mi-2 autoantigen is a pre-sumed helicase involved in transcriptional activation. Arthritis Rheum 1995;38:1389–99.
   PubMed Web of Science ®Google Scholar
• Ge Q, Nilasena DS, O'Brien CA, Frank MB, Targoff IN. Molecu-lar analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest 1995;96: 1730–7.
   Google Scholar
• Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic dis-ease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148–59.
   Google Scholar
• Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connec-tive tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 1980;59:239–48.
   PubMed Web of Science ®Google Scholar
• Lundberg I, Nennesmo I, Hedfors E. A clinical, serological, and histopathological study of myositis patients with and without anti-FtNP antibodies. Semin Arthritis Rheum 1992;22:127–38.
   Google Scholar
• Lerner MR, Steitz JA. Antibodies to small nuclear FtNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1979;76:5495–9.
   PubMed Web of Science ®Google Scholar
• Pettersson I, Hinterberger M, Mimori T, Gottlieb E, Steitz JA. The structure of mammalian small nuclear ribonucleoproteins. Identifi-cation of multiple protein components reactive with anti-(U1) ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem 1984;259: 5907–14.
   Google Scholar
• Takeda Y, Wang GS, Wang RJ, Anderson SK, Pettersson I, Amaki S, et al. Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to inves-tigate the clinical significance of autoantibodies to these polypep-tides. Clin Immunol Immunopathol 1989;50:213–30.
   PubMedGoogle Scholar
• Query CC, Keene JD. A human autoimmune protein associated with Ul RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 1987;51:211–20.
   PubMed Web of Science ®Google Scholar
• Guldner HH, Netter HJ, Szostecki C, Jaeger E, Will H. Human anti-p68 autoantibodies recognize a common epitope of Ul RNA containing small nuclear ribonucleoprotein and influenza B virus. J Exp Med 1990;171: 819–29.
   Google Scholar
• Mimori T, Hinterberger M, Pettersson I, Steitz JA. Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with sclero- derma-polymyositis overlap syndrome. J Biol Chem 1984;259:560–5.
   PubMed Web of Science ®Google Scholar
• Habets WJ, Sillekens FIG, Hoet MH, McAllister G, Lerner MR, van Venrooij WJ. Small nuclear RNA-associated proteins are immunologically related as revealed by mapping of autoimmune reactive B-cell epitopes. Proc Natl Acad Sci USA 1989;86:4674–8.
   Google Scholar
• Craft J, Mimori T, Olsen TL, Hardin JA. The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes. J Chin Invest 1987;81:1716–24.
   Google Scholar
• Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear pro-tein recognized by autoantibodies in sera from patients with poly-myositis-scleroderma overlap. J Chin Invest 1981;68:611–20.
   PubMed Web of Science ®Google Scholar
• Reeves WH. Use of monoclonal antibodies for the characteriza-tion of novel DNA-binding proteins recognized by human autoim-mune sera. J Exp Med 1985;161:18–39.
   PubMed Web of Science ®Google Scholar
• Yaneva M, Arnett FC. Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol 1989;76: 366–72.
   PubMed Web of Science ®Google Scholar
• Hirakata M, Suwa A, Kuwana M, Okano Y, Mimori T, Hardin JA, et al. Anti-Ku autoantibodies are associated with the DPB1*0501 gene. Arthritis Rheum 1994;37(Suppl.):574.
   Google Scholar
• Mimori T, Hardin JA, Steitz JA. Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem 1986;261:2274–8.
   Google Scholar
• Mimori T, Hardin JA. Mechanism of interaction between Ku protein and DNA. J Biol Chem 1986;261:10375–9.
   PubMed Web of Science ®Google Scholar
• Dvir A, Peterson SR, Knuth MW, Lu H, Dynan WS. Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. Proc Natl Acad Sci USA 1992;89:11920–4.
   Google Scholar
• Gottlieb TM, Jackson SP. The DNA-dependent protein kinase. Requirement for DNA ends and association with Ku antigen. Cell 1993;72:131–42.
   Google Scholar
• Rathmell WK, Chu G. Involvement of the Ku autoantigen in the cellular response to DNA double-strand breaks. Proc Natl Acad Sci USA 1994;91:7623–7.
   PubMed Web of Science ®Google Scholar
• Taccioli GE, Gottlieb TM, Blunt T, Priestley A, Demengeot J, Mizuta R, et al. Ku 80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 1994;265:1442–5.
   PubMed Web of Science ®Google Scholar
• Smider V, Rathmell WK, Lieber MR, Chu G. Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science 1994;266:288–91.
   PubMed Web of Science ®Google Scholar
• Suwa A, Hirakata M, Takeda Y, Okano Y, Mimori T, Inada S, et al. Autoantibodies to DNA-dependent protein kinase. Probes for the catalytic subunit. J Clin Invest 1996;97:1417–21.
   PubMed Web of Science ®Google Scholar
• Wolfe JF, Adelstein E, Sharp GC. Antinuclear antibody with dis-tinct specificity for polymyositis. J Clin Invest 1977;59:176–8.
   Google Scholar
• Oddis CV, Okano Y, Rudert WA, Truce° M, Duquesnoy RJ, Medsger TA Jr. Serum autoantibody to the nudeolar antigen PM-Sd: clinical and immunogenetic associations. Arthritis Rheum 1992;35:1211–7.
   Google Scholar
• Reichlin M, Maddison PJ, Targoff IN, Bunch TW, Arnett FC, Sharp GC, et al. Antibodies to a nudear/nucleolar antigen in patients with polymyositis-overlap syndrome. J Chin Immunol 1984;4:40–4.
   PubMed Web of Science ®Google Scholar
• Reimer G, Scheer U, Peters JM, Tan EM. Immunolocalization and partial characterization of a nucleolar antigen PM-Sd. Clinical and immunogenetic associations. Arthritis Rheum 1992;35:1211–7.
   PubMed Web of Science ®Google Scholar
• Gelpi C, Alguero A, Angeles Martinez M, Vidal S, Juarez C, Rodriguez-Sanchez JL. Identification of protein components reac-tive with anti-PM-Scl autoantibodies. Clin Exp Immunol 1990;81: 59–64.
   Google Scholar
• Walker EJ, Jeffray PD. Polymyositis and molecular mimicry: a mechanism of autoimmunity. Lancet 1986;i:605–7.
   Google Scholar
• Walker EJ, Jeffray PD. Sequence homology between encephalomyocarditis virus protein VP1 and histidyl-tFtNA syn-thetase supports a hypothesis of molecular mimicry in polymyosi-tis. Med Hypotheses 1988;25:21–5.
   PubMed Web of Science ®Google Scholar
• Ge Q, Trieu EP, Targoff IN. Primary structure and functional expression of human glycyl-tFtNA synthetase, an autoantigen in myositis. J Biol Chem 1994;269:28790–7.
   Google Scholar